PCA
Peddock Capital Advisors’s Novo Nordisk NVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $876K | Buy |
12,695
+1,280
| +11% | +$88.3K | 0.2% | 83 |
|
|
2025
Q1 | $793K | Buy |
11,415
+3,445
| +43% | +$239K | 0.2% | 86 |
|
|
2024
Q4 | $686K | Sell |
7,970
-491
| -6% | -$42.2K | 0.16% | 89 |
|
|
2024
Q3 | $1.01M | Buy |
8,461
+19
| +0.2% | +$2.26K | 0.24% | 81 |
|
|
2024
Q2 | $1.2M | Sell |
8,442
-655
| -7% | -$93.5K | 0.31% | 69 |
|
|
2024
Q1 | $1.17M | Buy |
9,097
+1,410
| +18% | +$181K | 0.31% | 72 |
|
|
2023
Q4 | $795K | Buy |
7,687
+2,047
| +36% | +$212K | 0.24% | 86 |
|
|
2023
Q3 | $513K | Buy |
5,640
+3,157
| +127% | +$287K | 0.17% | 94 |
|
|
2023
Q2 | $402K | Buy |
+2,483
| New | +$402K | 0.13% | 108 |
|